LumiraDx (LumiraDx) Purchase Of Investment : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Purchase Of Investment?

LumiraDx's purchase of investment for the three months ended in Jun. 2023 was $0.00 Mil. It means LumiraDx spent $0.00 Mil on purchasing investments. LumiraDx's purchase of investment for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Mar. 2023 ), LumiraDx spent the same money on purchasing investments in Jun. 2023 ($0.00 Mil).

LumiraDx Purchase Of Investment Historical Data

The historical data trend for LumiraDx's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Purchase Of Investment Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Purchase Of Investment

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Purchase Of Investment	Get a 7-Day Free Trial								-	-	-	-	-

LumiraDx Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

LumiraDx Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of LumiraDx's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

LMDXF:USA

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.